Contract 75A50124F61010
Glaxosmithkline, Llc · Department Of Health And Human Services · August 12, 2024
Glaxosmithkline, Llc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on August 12, 2024 for $28.83 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Durham, NC. This is a task or delivery order issued under parent IDIQ 75A50122D00002. The contract has been modified 7 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 31, 2026.
Contract details
- PIID
- 75A50124F61010
- Parent IDIQ
- 75A50122D00002
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; R&D Administrative Expenses
- Place of performance
- Durham, NC
- First action
- August 12, 2024
- Latest action
- March 31, 2026
Description
THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/202 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ 75A50122D00002.
Modification timeline
-
March 31, 2026Mod P00009 · Exercise An Option$7.79M
-
November 20, 2025Mod P00008 · Other Administrative Action$5.07M
-
September 17, 2025Mod P00007 · Other Administrative ActionTHIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/202 ( H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ 75A50122D00002.$5.06M
-
June 24, 2025Mod P00006 · Other Administrative ActionTHIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/202 ( H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ 75A50122D00002.$5.03M
-
August 29, 2024Mod P00004 · Other Administrative ActionTHE PURPOSE OF THIS MODIFICATION IS TO REFLECT THE FOLLOWING: 1. AT NO ADDITIONAL COST TO THE GOVERNMENT, RECEIVE THE 22 MF59 BULK LOTS TRANSFERRED FROM HSO10020090101C TO CONTRACT 75A50122D00004 / TA…$18.79M
-
August 27, 2024Mod P00001 · Exercise An OptionTHE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO A HHS DESIGNATED$14.42M
-
August 22, 2024Mod P00003 · Exercise An OptionTHE PURPOSE OF THIS MODIFICATION IS TO REFLECT THE FOLLOWING: 1. UPDATE THE STATEMENT OF WORK FOR OPTION 4. 2. EXERCISE AND FUND OPTION 4 WITH A QUANTITY OF 3.45M DOSES, AND A PERIOD OF PERFORMANCE FR…$18.79M
-
August 12, 2024Mod P00003 · Other Administrative ActionTHE PURPOSE OF THIS ADMINISTRATIVE MODIFICATION IS TO UPDATE ARTICLE G.2. CONTRACTING OFFICER'S REPRESENTATIVE (COR). BEZA SEYOUM REPLACES LAKSHMI JAYASHANKAR AS THE CONTRACTING OFFICE REPRESENTATIVE …$5.03M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 30, 2026 | $493.5K |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50124F61010?
Contract 75A50124F61010 is a federal contract awarded to Glaxosmithkline, Llc by Department Of Health And Human Services on August 12, 2024 for $28.83 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 7 times since the base award.
Who won contract 75A50124F61010?
Glaxosmithkline, Llc won contract 75A50124F61010 from Department Of Health And Human Services.
How much is contract 75A50124F61010 worth?
Contract 75A50124F61010 has obligated $28.83 million to date.